معرفی
Professor Paul Denny holds dual professorships in the Department of Biosciences and Department of Chemistry at Durham University, and is a Fellow of the Wolfson Research Institute for Health and Wellbeing. His research focuses on protozoan parasite lipid biosynthesis and drug discovery, particularly targeting Leishmania and Toxoplasma species. Key projects include investigating sphingolipid metabolism as a therapeutic target and developing antiparasitic compounds through repurposing and synthetic chemistry.
He has led major global initiatives such as the MRC-funded Global Network for NTDs, which fostered equitable research collaborations across 500+ scientists in 13 countries. Awards include the COMSTECH Distinguished Scholar (2025) and MRC Outstanding Team Impact Prize (2024).
Research interests span cell biology, lipid biochemistry, and molecular parasitology. Recent work emphasizes understanding host-parasite interactions, HSP90 modulation in Leishmania, and applying proteomic techniques to study parasite adaptation. He has supervised over 8 PhD/research students and holds patents on antileishmanial treatments.
- Education: Previously held research roles at Imperial College London and MRC National Institute for Medical Research before joining Durham in 2004
- Grants: Led £multi-million MRC Global Challenges Research Fund projects
- Labs: Active in Durham's Parasitology Research Group and interdisciplinary drug discovery networks
